These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38864483)

  • 1. Integrated whole-exome and bulk transcriptome sequencing delineates the dynamic evolution from preneoplasia to invasive lung adenocarcinoma featured with ground-glass nodules.
    Zhou D; Li YQ; Liu QX; Deng XF; Chen L; Li MY; Zhang J; Lu X; Zheng H; Dai JG
    Cancer Med; 2024 Jun; 13(11):e7383. PubMed ID: 38864483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics.
    Zhu J; Fan Y; Xiong Y; Wang W; Chen J; Xia Y; Lei J; Gong L; Sun S; Jiang T
    Exp Mol Med; 2022 Nov; 54(11):2060-2076. PubMed ID: 36434043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of lung adenocarcinoma from preneoplasia to invasive adenocarcinoma.
    Zhu J; Wang W; Xiong Y; Xu S; Chen J; Wen M; Zhao Y; Lei J; Jiang T
    Cancer Med; 2023 Mar; 12(5):5545-5557. PubMed ID: 36325966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.
    Dejima H; Hu X; Chen R; Zhang J; Fujimoto J; Parra ER; Haymaker C; Hubert SM; Duose D; Solis LM; Su D; Fukuoka J; Tabata K; Pham HHN; Mcgranahan N; Zhang B; Ye J; Ying L; Little L; Gumbs C; Chow CW; Estecio MR; Godoy MCB; Antonoff MB; Sepesi B; Pass HI; Behrens C; Zhang J; Vaporciyan AA; Heymach JV; Scheet P; Lee JJ; Wu J; Futreal PA; Reuben A; Kadara H; Wistuba II; Zhang J
    Nat Commun; 2021 May; 12(1):2722. PubMed ID: 33976164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and immune profiling of pre-invasive lung adenocarcinoma.
    Chen H; Carrot-Zhang J; Zhao Y; Hu H; Freeman SS; Yu S; Ha G; Taylor AM; Berger AC; Westlake L; Zheng Y; Zhang J; Ramachandran A; Zheng Q; Pan Y; Zheng D; Zheng S; Cheng C; Kuang M; Zhou X; Zhang Y; Li H; Ye T; Ma Y; Gao Z; Tao X; Han H; Shang J; Yu Y; Bao D; Huang Y; Li X; Zhang Y; Xiang J; Sun Y; Li Y; Cherniack AD; Campbell JD; Shi L; Meyerson M
    Nat Commun; 2019 Nov; 10(1):5472. PubMed ID: 31784532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
    Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J
    Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
    Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
    Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinoma.
    Nie M; Yao K; Zhu X; Chen N; Xiao N; Wang Y; Peng B; Yao L; Li P; Zhang P; Hu Z
    Nat Commun; 2021 Nov; 12(1):6479. PubMed ID: 34759281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-Assisted Improvements in the Accuracy of the Intraoperative Frozen Section Examination of Ground-Glass Density Nodules.
    Xinli W; Xiaoshuang S; Chengxin Y; Qiang Z
    Comput Math Methods Med; 2022; 2022():8967643. PubMed ID: 35035526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling using targeted RNA-sequencing to elucidate the progression from histologically normal lung tissues to non-invasive lesions in invasive lung adenocarcinoma.
    Kadonaga T; Sakabe T; Kidokoro Y; Haruki T; Nosaka K; Nakamura H; Umekita Y
    Virchows Arch; 2022 Apr; 480(4):831-841. PubMed ID: 35067776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.
    Yagi T; Yamazaki M; Ohashi R; Ogawa R; Ishikawa H; Yoshimura N; Tsuchida M; Ajioka Y; Aoyama H
    Jpn J Radiol; 2018 Feb; 36(2):113-121. PubMed ID: 29273964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities].
    Xu Y; Sun Q; Wang S; Zhu H; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Ji J; Li Z; Zhu P; Sun Y; Liu T; Yin R; Xu L
    Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):889-900. PubMed ID: 38151328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
    Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
    Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Progression and Heterogeneity in Multiple Nodules of Lung Adenocarcinoma.
    He Y; Liu X; Wang H; Wu L; Jiang M; Guo H; Zhu J; Wu S; Sun H; Chen S; Zhu Y; Zhou C; Yang Y
    Small Methods; 2021 Jun; 5(6):e2100082. PubMed ID: 34927899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung-PNet: An Automated Deep Learning Model for the Diagnosis of Invasive Adenocarcinoma in Pure Ground-Glass Nodules on Chest CT.
    Qi K; Wang K; Wang X; Zhang YD; Lin G; Zhang X; Liu H; Huang W; Wu J; Zhao K; Liu J; Li J; Zhang X
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329674. PubMed ID: 37493322
    [No Abstract]   [Full Text] [Related]  

  • 18. Systems biology analysis reveals new insights into invasive lung cancer.
    Li D; Yang W; Arthur C; Liu JS; Cruz-Niera C; Yang MQ
    BMC Syst Biol; 2018 Dec; 12(Suppl 7):117. PubMed ID: 30547817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma.
    Lin Y; Li D; Hui H; Miao H; Luo M; Roy B; Chen B; Zhang W; Shao D; Ma D; Jie Y; Qiu F; Li H; Jiang B
    Front Oncol; 2024; 14():1389618. PubMed ID: 38803537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering lung adenocarcinoma evolution: Integrative single-cell genomics identifies the prognostic lung progression associated signature.
    Zhang P; Yang Z; Liu Z; Zhang G; Zhang L; Zhang Z; Fan J
    J Cell Mol Med; 2024 Jun; 28(11):e18408. PubMed ID: 38837585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.